Fig. 4From: Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case reportUrodynamic study during treatment with orally administered vibegron after changing from propiverine. FSBF first sensation of bladder filling, FDV first desire to void, NDV normal desire to void, MCC maximum cystometric capacityBack to article page